Agios Pharmaceuticals (NASDAQ:AGIO) executives highlighted multiple upcoming clinical and regulatory milestones during the ...

PYRUKYND is also approved for adults with PK deficiency in the U.S. and Europe, and a marketing application for PYRUKYND in thalassemia is currently under review by the European Commission. In the U.S ...

Researchers from the University of Seville have participated in research to identify the molecular details of the regulation of an enzyme essential for sugar metabolism and closely linked to cell ...

Pyruvate kinase (PK) catalyzes the last step in glycolysis, the pathway by which glucose is metabolized. In humans, the M1 isoform of PK (PKM1) is constitutively active, but the activity of the highly ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage PYRUKYND commercialization in the Gulf Region CAMBRIDGE, ...

Introduction: Aortic atherosclerotic aneurysm develops asymptomatically with gradual progression and suddenly become symptomatic rupture. Inflammation is a fundamental pathophysiology of atherogenesis ...

Scientists led by a team at the Medical Research Council (MRC) Mitochondrial Biology Unit, University of Cambridge, have worked out how a molecular machine found in mitochondria—the “powerhouses” of ...

Fifty years since its discovery, scientists have finally worked out how a molecular machine found in mitochondria, the 'powerhouses' of our cells, allows us to make the fuel we need from sugars, a ...

Pyrukynd (mitapivat) is a prescription drug that’s used to treat hemolytic anemia. Pyrukynd comes as an oral tablet. Pyrukynd is used to treat hemolytic anemia in adults who have pyruvate kinase (PK) ...

This important study investigates the molecular mechanisms underpinning how the tumor necrosis factor alpha-induced protein (TIPE) regulates aerobic glycolysis to promote tumor growth in melanoma.

HSCT, hematopoietic allogeneic stem cell transplantation; GvHD, graft-versus-host disease; aGvHD, acute graft-versus-host disease; Flu, fludarabine; Bu, busulfan; Cy ...